Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luis A. Nivelo"'
Autor:
Jashodeep Datta, Nipun Merchant, Anna Bianchi, Iago De Castro Silva, Ifeanyichukwu Ogobuiro, Samara Singh, Vanessa Garrido, Lucas Caeiro, Haleh Amirian, Luis Alberto Nivelo, Karthik Rajkumar, Andrew Adams, Nagaraj Nagathihalli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/328b90a2e199438ca66ec6e837683583
Autor:
Jashodeep Datta, Nipun B. Merchant, Dmitry I. Gabrilovich, Ben Z. Stanger, Eneda Toska, Alejandro V. Villarino, Krishna Komanduri, Roberta Brambilla, William L. Hwang, Elizabeth A. Montgomery, Nagaraj S. Nagathihalli, Carina Shiau, Yuguang Ban, Jian Zhang, Ifeanyichukwu C. Ogobuiro, Haleh Amirian, Oliver Umland, Zhiqun Zhou, Austin R. Dosch, Christine I. Rafie, Eric Wieder, Shannon J. Saigh, Despina S. Kolonias, Luis A. Nivelo, Xinyu Guo, Vanessa T. Garrido, Siddharth Mehra, Samara Singh, Nilesh U. Deshpande, Iago De Castro Silva, Anna Bianchi
We have shown that KRAS–TP53 genomic coalteration is associated with immune-excluded microenvironments, chemoresistance, and poor survival in pancreatic ductal adenocarcinoma (PDAC) patients. By treating KRAS–TP53 cooperativity as a model for hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c006c946ca4358d4c3811305ca5a79
https://doi.org/10.1158/2159-8290.c.6655455.v1
https://doi.org/10.1158/2159-8290.c.6655455.v1
Autor:
Jashodeep Datta, Nipun B. Merchant, Dmitry I. Gabrilovich, Ben Z. Stanger, Eneda Toska, Alejandro V. Villarino, Krishna Komanduri, Roberta Brambilla, William L. Hwang, Elizabeth A. Montgomery, Nagaraj S. Nagathihalli, Carina Shiau, Yuguang Ban, Jian Zhang, Ifeanyichukwu C. Ogobuiro, Haleh Amirian, Oliver Umland, Zhiqun Zhou, Austin R. Dosch, Christine I. Rafie, Eric Wieder, Shannon J. Saigh, Despina S. Kolonias, Luis A. Nivelo, Xinyu Guo, Vanessa T. Garrido, Siddharth Mehra, Samara Singh, Nilesh U. Deshpande, Iago De Castro Silva, Anna Bianchi
Differentially expressed pathways comparing transcriptomes in KRAS-TP53 co-altered (n=23) and KRAS-altered/TP53WT (n=5) derived from Cancer Cell Line Encyclopedia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92246783d8a78ae68e4fcb7019f7aad2
https://doi.org/10.1158/2159-8290.22960614
https://doi.org/10.1158/2159-8290.22960614
Autor:
Siddharth Mehra, Vanessa Garrido, Samara Singh, Iago De Castro Silva, Zhiqun Zhou, Supriya Srinivasan, Luis Alberto Nivelo, Anna Bianchi, Andrew Adams, Haleh Amirian, Lluis Morey, Ban Yuguang, Alejandro Villarino, Jashodeep Datta, Nipun Merchant, Nagaraj Nagathihalli
Publikováno v:
Cancer Research. 83:653-653
Background: Pancreatic ductal adenocarcinoma (PDAC) due to its unique genetic makeup and immunosuppressive tumor microenvironment (TME) produce a lack of response to current therapies. Macrophages, constitute a large innate immune subset and play a v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4a7bf2471561b85010487b4728d8f47
https://doi.org/10.1158/1538-7445.am2023-653
https://doi.org/10.1158/1538-7445.am2023-653
Autor:
Siddharth Mehra, Vanessa T. Garrido, Samara Singh, Iago De Castro Silva, Anna Bianchi, Luis A. Nivelo, Nilesh U. Deshpande, Austin R. Dosch, Zhou Zhiqun, Supriya Srinivasan, Christine I. Rafie, Ifeanyichukwu C. Ogobuiro, Xi Chen, Alejandro Villarino, Jashodeep Datta, Nipun B. Merchant, Nagaraj Nagathihalli
Publikováno v:
Cancer Research. 82:C040-C040
Background: Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy, and its unique genetic makeup and immunosuppressive tumor microenvironment (TME) produce a lack of response to current therapies. Previously, we have identified Cyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6b0a2711b537b4a2b2b29ea5fb33aae
https://doi.org/10.1158/1538-7445.panca22-c040
https://doi.org/10.1158/1538-7445.panca22-c040
Autor:
Siddharth Mehra, Vanessa Garrido, Samara Singh, Iago D Silva, Luis Alberto Nivelo, Anna Bianchi, Shrey Modi, Zhiqun Zhou, Austin Dosch, Nilesh Deshpande, Supriya Srinivasan, Christine Rafie, Ifeanyichukwu Ogobuiro, Xi Chen, Alejandro Villarino, Jashodeep Datta, Nipun Merchant, Nagaraj Nagathihalli
Publikováno v:
Cancer Research. 82:1328-1328
Background: Pancreatic ductal adenocarcinoma (PDAC) remains a major therapeutic challenge with hallmarks including oncogenic mutations, desmoplastic architecture, and an immunosuppressive tumor microenvironment (TME). Previously, we have identified C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::430028b5896b549adee6d2fdd2c80041
https://doi.org/10.1158/1538-7445.am2022-1328
https://doi.org/10.1158/1538-7445.am2022-1328